Functional Vision and Quality of Life in a Modern Society - With Emphasis on Myopia and Cerebral Visual Impairment Among Youth
Society has become increasingly digital, and many everyday services have been replaced by digital self-service solutions. This puts greater demands on our vision and our ability to interpret what we see. At the same time, the number of children with nearsightedness (myopia) has increased rapidly. In some parts of Asia, as many as 60-70% of students in seventh grade are nearsighted (1), and a similar trend may develop in Europe.
Nearsightedness is becoming a growing challenge in pediatric eye care. High myopia can lead to complications that require early detection and prevention. There are now several ways to slow down its progression, such as special contact lenses, glasses, and eye drops (2). However, the scientific evidence for these treatments varies, and there are currently no national or Nordic guidelines on how to use them. In addition, myopia may have a major impact on children's quality of life.
Currently, there is no validated Swedish questionnaire that measures vision related quality of life across all age groups in children and adolescents. To address this, researchers in the United States developed the Pediatric Eye Questionnaire (PedEyeQ) in 2019 (3). It is already available in English and Spanish and takes into account both the child's and the parent's perspectives on vision and daily life.
The aim of this study is to translate, culturally adapt and test the PedEyeQ in Swedish children and adolescents, and to investigate how common refractive errors, especially nearsightedness - are today compared to 20-30 years ago.
The study will include 300 healthy children and adolescents aged 0-17 years, divided into three age groups: 0-4 years, 5-11 years, and 12-17 years. Participants will be recruited through child health centers, preschools, and schools in the Örebro region.
All participants will visit the eye clinic for a detailed eye examination, including:
- Testing distance and near visual acuity
- Measuring eye refraction (with and without eye drops that temporarily relax the eye's focusing muscles)
- Imaging the retina using Optical Coherence Tomography (OCT)
- Measuring eye length and corneal shape
- Checking eye pressure and contrast sensitivity
Children and parents will also answer questions about how the child's vision affects everyday life and wellbeing. For the youngest children (0-4 years), only parents will answer the questions.
The PedEyeQ will be translated into Swedish following the International Society for Pharmacoeconomics and Outcome Research (ISPOR) (4) guidelines to make sure it is culturally relevant and easy to understand. The Swedish version will then be tested to ensure it is accurate and reliable.
All information collected in the study will be stored securely and anonymously. The results will also be compared with data from a similar cohort conducted in the 1990s to see if vision problems have become more common over time (5).
This project will provide new knowledge about children's vision and quality of life in Sweden. A validated Swedish version of the PedEyeQ can be used both in healthcare and research to better understand how vision affects children's daily lives. The study will also offer updated information on the frequency of refractive errors among Swedish children and adolescents - knowledge that is essential for developing preventive strategies and improving eye care for the future.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Society has undergone extensive digitalization, in which many service functions have been replaced by digital self-service solutions. This development requires a good visual function and on the ability to interpret visual information. Concurrently, there has been a marked increase in nearsightedness (myopia) among children. In parts of Asia, 60-70% of students in seventh grade are myopic (1), and a similar trend may emerge in Europe.
The increase of myopia might become major challenge within pediatric ophthalmology. High myopia can lead to vision-related complications that require early diagnosis and preventive measures. Preventive interventions-such as specialized contact lenses, spectacle designs, and pharmacological treatments as for example low-dose atropine, are now available on the market (2). However, the scientific evidence supporting these methods varies, and there is currently no national or Nordic consensus regarding their implementation. Furthermore the condition may have substantial implications for affected children's quality of life.
At present, there is no validated Swedish-language instrument for assessing vision-related quality of life in children and adolescents that encompasses all age groups, despite the widely recognized importance of such measures from both a PROM (Patient-Reported Outcome Measure) and PREM (Patient-Reported Experience Measure) perspective. A new questionnaire, the Paediatric Eye Questionnaire (PedEyeQ) was developed in the United States in 2019 for children and adolescents aged 0-17 years (3). Since its introduction, it has been used in English and subsequently translated into Spanish. The questionnaire comprises four domains measuring different aspects of vision-related quality of life, with each domain consisting of ten questions. To achieve a comprehensive understanding, the questionnaire incorporates both the child's and the parent's perspectives, and it includes separate age-appropriate versions for different developmental stages.
The aim of this study is to validate the PedEyeQ on a healthy Swedish cohort and to study the prevalence and changes in the amount of refractive errors in the same cohort and compare them to another healthy cohort investigated two decades ago.
Validation of PedEyeQ: We intend to translate the PedEyeQ into Swedish and validate the instrument in a cohort of healthy children and adolescents born in Sweden. The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group. Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population. Recruitment will primarily take place through child healthcare centers, preschools, and schools in Örebro and surrounding areas.
Participants will be invited to the ophthalmology clinic for a comprehensive examination, including: assessment of distance and near visual acuity, optical coherence tomography (OCT) to document retinal structure, PedEyeQ for assessment of vision-related quality of life, and PedsQL (Pediatric Quality of Life Inventory) for assessment of general quality of life.
For children aged 0-4 years, only parents will complete the quality-of-life assessment. In the older groups, both the child and the parents will complete the questionnaires independently, allowing for comparison between the two perspectives.
The validation process will follow the International Society for Pharmacoeconomics and Outcome Research (ISPOR) recommendations for the translation and cultural adaptation of questionnaires (4). The original American PedEyeQ will be translated using a forward-backward translation procedure. The forward translation from English to Swedish will be carried out by a physician with strong subject knowledge and proficiency in both languages. The translation will be reviewed and proofread by an expert panel consisting of the principal supervisor and co-supervisors. The finalized Swedish version will then be back-translated into English. Emphasis during translation will be placed on conceptual and cultural equivalence, rather than literal translation. The research team will discuss any discrepancies between the original and back-translated versions to establish a final Swedish version of the instrument.
The Swedish questionnaire will then be tested in the described healthy study population. To ensure that participants can understand and adequately respond to the items, all participants will take part in a cognitive interview regarding the questionnaire. Following data collection, psychometric analyses will be conducted to evaluate validity, reliability, reproducibility, responsiveness, and factor structure.
Prevalence of refractive errors - The cohort described above will be recruited as previously outlined. In addition to completing the questionnaires, all participating children will undergo a comprehensive ophthalmological examination according to a standardized protocol, which includes measurements of several factors influencing ocular refraction.
The examination will include: Assessment of distance and near visual acuity, autorefractor measurements both with and without cycloplegia (i.e., after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam, measurement of intraocular pressure using a non-contact, non-anesthetic method, and assessment of contrast sensitivity.
All collected data will be stored in a dedicated, pseudonymized research database (FoU database). Descriptive analyses will be performed to determine the prevalence of refractive errors within the study population. The cohort will also be compared to a corresponding reference group examined during the 1990s, in order to assess potential temporal changes in the prevalence of refractive errors among children and adolescents (5).
For statistical analysis, the Mann-Whitney U test will be used to compare continuous variables, while Fisher's exact test and the Chi-square test will be applied for comparisons of dichotomous variables. Regression analyses will be conducted to explore associations between risk factors and myopia, as well as relationships between myopia and quality of life.
Furthermore, the described cohort will serve as a reference population, allowing for the extraction of age- and sex-matched control groups for future pediatric ophthalmological studies.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Alexandra UC Wrede, MD
- Phone Number: +358400791907
- Email: alexandra.wrede@regionorebrolan.se
Study Locations
-
-
-
Örebro, Sweden
- Recruiting
- Örebro university hospital
-
Contact:
- Alexandra Wrede, M.D.
- Phone Number: +358400791907
- Email: alexandra.wrede@regionorebrolan.se
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy children
Exclusion Criteria:
- Children with ophthalmological diagnosis followed frequently by the ophthalmological clinic
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Healthy children 0-17 years
The study group will consist of 300 participants aged 0-17 years, divided into the following age-based subgroups corresponding to the PedEyeQ versions: 0-4 years, 5-11 years, and 12-17 years, with 100 participants in each group.
Efforts will be made to ensure that sex distribution, ethnicity, socioeconomic status, and birth parameters reflect those of the general population.
Recruitment will primarily take place through child health centers, preschools, and schools in Örebro and surrounding areas.
|
The examination will include: Assessment of distance and near visual acuity, Autorefraction measurements both with and without cycloplegia (i.e., after administration of dilating eye drops to temporarily suspend accommodation and obtain accurate refraction values), Optical Coherence Tomography (OCT) to measure retinal thickness and to detect potential pathology such as edema, deposits, or thinning, Axial length measurement, Non-invasive corneal mapping of corneal thickness, curvature, and refractive power using Pentacam,Measurement of intraocular pressure using a non-contact, non-anesthetic method, and Assessment of contrast sensitivity. It will also include questionnaires as the PedEyeQ described earlier, the PedQoL. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Prevalence of refractive errors
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
General Publications
- Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005 Mar-Apr;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x.
- Gronlund MA, Andersson S, Aring E, Hard AL, Hellstrom A. Ophthalmological findings in a sample of Swedish children aged 4-15 years. Acta Ophthalmol Scand. 2006 Apr;84(2):169-76. doi: 10.1111/j.1600-0420.2005.00615.x.
- Hatt SR, Leske DA, Castaneda YS, Wernimont SM, Liebermann L, Cheng-Patel CS, Birch EE, Holmes JM. Development of Pediatric Eye Questionnaires for Children With Eye Conditions. Am J Ophthalmol. 2019 Apr;200:201-217. doi: 10.1016/j.ajo.2019.01.001. Epub 2019 Jan 14.
- Cooper J, Tkatchenko AV. A Review of Current Concepts of the Etiology and Treatment of Myopia. Eye Contact Lens. 2018 Jul;44(4):231-247. doi: 10.1097/ICL.0000000000000499.
- Li SM, Wei S, Atchison DA, Kang MT, Liu L, Li H, Li S, Yang Z, Wang Y, Zhang F, Wang N. Annual Incidences and Progressions of Myopia and High Myopia in Chinese Schoolchildren Based on a 5-Year Cohort Study. Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):8. doi: 10.1167/iovs.63.1.8.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Region Örebro County
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
NCT07378215RecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-Life
-
NCT02901639UnknownImproving Quality of Life
-
NCT04239183UnknownQuality of Life of Colostomized Patient
-
NCT04761367CompletedImprove Quality of Life
-
NCT05722249CompletedProfessional Quality of Life
-
NCT06014671CompletedBreif Description: Patients' Quality of Life of
-
NCT06262334RecruitingHealth Related Quality of Life
-
NCT01155076CompletedHealth-related Quality of Life
-
NCT01784497CompletedHealth Related Quality of Life
Clinical Trials on ophthalmological examination
-
NCT03464994Completed
-
NCT04978740CompletedMast Cell Activation Syndrome | Urticaria Pigmentosa | Mast Cell Activation Disease | Mast Cell Disease
-
NCT03979001CompletedObstructive Sleep Apnea Syndrome
-
NCT04386824CompletedBehcet Syndrome | Erectile Dysfunction | Behçet Disease
-
NCT03373942CompletedGlaucoma, Open-Angle
-
NCT03459508CompletedPrimary Antiphospholipid Syndrome
-
NCT05939752TerminatedIbrutinib Treatment
-
NCT05264818RecruitingGlaucoma | Primary Open-angle Glaucoma
-
NCT07174141RecruitingTreatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)